Progastrin-releasing peptide (ProGRP) levels at baseline and following chemoradiotherapy correlated with progression-free survival (PFS) and overall survival (OS) outcomes in patients with limited-stage small cell lung cancer (SCLC), according…

Progastrin-releasing peptide (ProGRP) levels at baseline and following chemoradiotherapy correlated with progression-free survival (PFS) and overall survival (OS) outcomes in patients with limited-stage small cell lung cancer (SCLC), according…